Cwm, LLC Charles River Laboratories International, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,542 shares of CRL stock, worth $304,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,542

Previous 2,085 26.04%

Holding current value

$304,930

Previous $431,000 29.47%

% of portfolio

0.0%

Previous 0.0%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$187.96 - $245.29 $102,062 - $133,192	-543 Reduced 26.04%	1,542 $304,000
Q2 2024 Jul 09, 2024	BUY	$206.39 - $268.73 $98,241 - $127,915	476 Added 29.58%	2,085 $431,000
Q1 2024 Apr 05, 2024	BUY	$203.52 - $273.43 $112,750 - $151,480	554 Added 52.51%	1,609 $436,000
Q4 2023 Feb 01, 2024	SELL	$164.52 - $238.84 $6,087 - $8,837	-37 Reduced 3.39%	1,055 $249,000
Q3 2023 Oct 11, 2023	SELL	$194.44 - $217.61 $1,555 - $1,740	-8 Reduced 0.73%	1,092 $214,000
Q2 2023 Aug 03, 2023	BUY	$183.71 - $210.25 $41,151 - $47,096	224 Added 25.57%	1,100 $231,000
Q1 2023 Apr 28, 2023	BUY	$191.89 - $259.92 $5,181 - $7,017	27 Added 3.18%	876 $177,000
Q4 2022 Feb 01, 2023	BUY	$197.11 - $250.07 $20,105 - $25,507	102 Added 13.65%	849 $185,000
Q3 2022 Oct 27, 2022	BUY	$182.44 - $250.54 $182 - $250	1 Added 0.13%	747 $147,000
Q2 2022 Jul 28, 2022	BUY	$204.13 - $302.4 $85,734 - $127,007	420 Added 128.83%	746 $160,000
Q1 2022 Apr 21, 2022	BUY	$255.51 - $362.11 $24,528 - $34,762	96 Added 41.74%	326 $93,000
Q4 2021 Jan 31, 2022	BUY	$351.38 - $448.68 $27,407 - $34,997	78 Added 51.32%	230 $87,000
Q1 2021 Sep 15, 2021	BUY	$249.67 - $299.48 $8,239 - $9,882	33 Added 27.73%	152 $56,000
Q1 2021 Apr 27, 2021	SELL	$249.67 - $299.48 $8,239 - $9,882	-33 Reduced 21.71%	119 $34,000
Q4 2020 Sep 15, 2021	BUY	$222.0 - $252.62 $3,996 - $4,547	18 Added 13.43%	152 $56,000
Q4 2020 Jan 27, 2021	SELL	$222.0 - $252.62 $3,996 - $4,547	-18 Reduced 11.84%	134 $33,000
Q3 2020 Sep 15, 2021	BUY	$175.56 - $226.45 $2,457 - $3,170	14 Added 10.14%	152 $56,000
Q3 2020 Oct 19, 2020	SELL	$175.56 - $226.45 $2,457 - $3,170	-14 Reduced 9.21%	138 $31,000
Q2 2020 Sep 15, 2021	BUY	$118.84 - $189.72 $3,208 - $5,122	27 Added 21.6%	152 $56,000
Q2 2020 Jul 22, 2020	SELL	$118.84 - $189.72 $3,208 - $5,122	-27 Reduced 17.76%	125 $22,000
Q1 2020 Sep 15, 2021	SELL	$98.9 - $178.34 $3,065 - $5,528	-31 Reduced 16.94%	152 $56,000
Q1 2020 Apr 28, 2020	BUY	$98.9 - $178.34 $3,065 - $5,528	31 Added 20.39%	183 $23,000
Q4 2019 Sep 14, 2021	SELL	$126.05 - $152.76 $15,378 - $18,636	-122 Reduced 44.53%	152 $56,000
Q4 2019 Jan 27, 2020	BUY	$126.05 - $152.76 $15,378 - $18,636	122 Added 80.26%	274 $42,000
Q3 2019 Sep 14, 2021	SELL	$125.07 - $143.67 $29,391 - $33,762	-235 Reduced 60.72%	152 $56,000
Q3 2019 Oct 22, 2019	BUY	$125.07 - $143.67 $29,391 - $33,762	235 Added 154.61%	387 $51,000
Q2 2019 Sep 14, 2021	SELL	$123.4 - $148.55 $8,391 - $10,101	-68 Reduced 30.91%	152 $56,000
Q2 2019 Jul 31, 2019	BUY	$123.4 - $148.55 $8,391 - $10,101	68 Added 44.74%	220 $31,000
Q1 2019 Sep 02, 2021	SELL	$104.82 - $146.73 $29,035 - $40,644	-277 Reduced 64.57%	152 $0
Q1 2019 Apr 22, 2019	BUY	$104.82 - $146.73 $27,462 - $38,443	262 Added 156.89%	429 $62,000
Q4 2018 Jan 25, 2019	BUY	$105.09 - $137.23 $11,349 - $14,820	108 Added 183.05%	167 $19,000
Q3 2018 Oct 29, 2018	BUY	$112.11 - $134.54 $448 - $538	4 Added 7.27%	59 $8,000
Q2 2018 Jul 31, 2018	BUY	$102.37 - $117.25 $5,630 - $6,448	55 New	55 $6,000
Q1 2018 Apr 26, 2018	SELL	$98.19 - $115.2 $4,418 - $5,184	-45 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$96.72 - $109.26 $4,352 - $4,916	45	45 $5,000

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account